Sebastian Theurich

Oberarzt, Hämatologie und Onkologie, W2 Professor für Krebs- und Immunmetabolismus

Klinikum der Universität München

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Sebastian Theurich is an Oberarzt and W2 Professor for Cancer and Immunometabolism at Klinikum der Universität München, Germany. His research focuses on hematology, oncology, and the impact of immune therapies on cancer treatment outcomes. Recent publications include studies on patient health-related internet use during the COVID-19 pandemic, body composition in melanoma therapy, and advances in CAR T cell therapy.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Wolfgang G. Kunz

University Hospital

GERMANY

View details

Philipp Karschnia

LMU University Hospital

GERMANY

View details

Marion Subklewe

LMU University Hospital

GERMANY

View details

Franziska Jundt

Prof. Dr.

University of Wuerzburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sebastian Theurich

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Health-Related Internet Use Among Outpatients Undergoing Cancer Treatment During the COVID-19 Pandemic: Cross-Sectional Survey Study

Extensive extramedullary haematopoiesis in a patient with non‐transfusion‐dependent beta‐thalassaemia

Body Composition and Inflammation as emerging Sex-specific Prognostic Factors in Patients with Advanced Cutaneous Melanoma undergoing Immune Checkpoint-Inhibition Therapy – a Prospective Pilot Study

A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy

Beyond CAR T cells: Exploring alternative cell sources for CAR-like cellular therapies

Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma

Exercise Therapy in Oncology The Impact on Quality of Life and Side Effects

Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET-EVER trial

Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy – A systematic review and meta-analysis

STING agonism turns human T cells into interferon‐producing cells but impedes their functionality

Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy

CD33 BiTE<sup>®</sup> molecule-mediated immune synapse formation and subsequent T-cell activation is determined by the expression profile of activating and inhibitory checkpoint molecules on AML cells

Exercise interventions for adults with cancer receiving radiation therapy alone

Malignant Melanoma and Obesity,Malignes Melanom und Adipositas: eine Übersichtsarbeit

Risk Stratification Based on a Pattern of Immunometabolic Host Factors Is Superior to Body Mass Index—Based Prediction of COVID-19-Associated Respiratory Failure

Treatment‐specific evaluation of the modified Glasgow‐Prognostic‐Score in patients with advanced cutaneous melanoma

Long-term physical training in adolescent sprint and middle distance swimmers alters the composition of circulating T and NK cells which correlates with soluble ICAM-1 serum concentrations

[Primary and Secondary Prevention of Multiple Myeloma - Lifestyle Factors and Supportive Measures].

Addition of Radiotherapy to Immunotherapy: Effects on Outcome of Different Subgroups Using a Propensity Score Matching

Evaluating body composition by combining quantitative spectral detector computed tomography and deep learning-based image segmentation.

[Primary and Secondary Prevention of Multiple Myeloma - Lifestyle Factors and Supportive Measures].

ZBTB7A prevents RUNX1-RUNX1T1-dependent clonal expansion of human hematopoietic stem and progenitor cells.

Collaborators (4)

Wolfgang G. Kunz

Philipp Karschnia

Marion Subklewe

Franziska Jundt

Make your next move.